MaxCyte, Inc. Capital Expenditures Incurred but Not yet Paid
MaxCyte, Inc. (MXCT) reported Capital Expenditures Incurred but Not yet Paid of $24.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-13
- MaxCyte, Inc. capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $24.00K.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $4.00K, a 93.55% decline year-over-year.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$62.00K.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $62.00K, a 77.78% decline year-over-year.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $33.00K, a 65.98% decline from fiscal 2024.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $97.00K, a 82.86% decline from fiscal 2023.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $566.00K, a 55.92% increase from fiscal 2022.
- MaxCyte, Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $363.00K, a 22.47% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 3 month as first filed | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 6 month as first filed | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 9 month as first filed | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $24.00K 10-Q · filed 2026-05-13 | $28.00K derived: sum of 2 quarters · filed 2026-05-13 | -$34.00K derived: sum of 3 quarters · filed 2026-05-13 | ||||
| 2025-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$58.00K derived: sum of 2 quarters · filed 2026-03-25 | $33.00K 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $29.00K 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | $91.00K 10-Q · filed 2026-08-13 | ||||||
| 2024-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $17.00K derived: sum of 2 quarters · filed 2026-03-25 | $81.00K derived: sum of 3 quarters · filed 2026-03-25 | $97.00K 10-K · filed 2026-03-25 | |||
| 2024-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $19.00K derived: sum of 2 quarters · filed 2025-11-13 | $35.00K 10-Q · filed 2025-11-13 | $314.00K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | $64.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $80.00K 10-Q · filed 2025-08-06 | $359.00K derived: sum of 3 quarters · filed 2025-08-06 | $150.00K derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-31 | $16.00K 10-Q · filed 2025-05-08 | $295.00K derived: sum of 2 quarters · filed 2025-05-08 | $86.00K derived: sum of 3 quarters · filed 2025-05-08 | -$49.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $279.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $70.00K derived: sum of 2 quarters · filed 2025-03-11 | -$65.00K derived: sum of 3 quarters · filed 2025-03-11 | $566.00K 10-K · filed 2025-03-11 | |||
| 2023-09-30 | -$209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$344.00K derived: sum of 2 quarters · filed 2024-11-06 | $287.00K 10-Q · filed 2024-11-06 | $287.30K 10-Q · filed 2023-11-08 | -$169.40K derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | -$135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $496.00K 10-Q · filed 2024-08-06 | $495.50K 10-Q · filed 2023-08-09 | $39.60K derived: sum of 3 quarters · filed 2024-08-06 | -$215.70K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $631.00K 10-Q · filed 2024-05-07 | $630.90K 10-Q · filed 2023-05-10 | $174.60K derived: sum of 2 quarters · filed 2024-05-07 | -$80.70K derived: sum of 3 quarters · filed 2024-05-07 | $950.80K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | -$456.40K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$711.70K derived: sum of 2 quarters · filed 2024-03-12 | $319.80K derived: sum of 3 quarters · filed 2024-03-12 | $363.00K 10-K · filed 2024-03-12 | |||
| 2022-09-30 | -$255.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $776.20K derived: sum of 2 quarters · filed 2023-11-08 | $819.40K 10-Q · filed 2023-11-08 | $961.85K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.07M 10-Q · filed 2023-08-09 | $1.07M 10-Q · filed 2022-08-10 | $1.22M derived: sum of 3 quarters · filed 2023-08-09 | $1.37M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $43.20K 10-Q · filed 2023-05-10 | $185.65K derived: sum of 2 quarters · filed 2023-05-10 | $333.60K derived: sum of 3 quarters · filed 2023-05-10 | $318.40K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $142.45K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $290.40K derived: sum of 2 quarters · filed 2023-03-15 | $275.20K derived: sum of 3 quarters · filed 2023-03-15 | $296.40K 10-K · filed 2023-03-15 | |||
| 2021-09-30 | $147.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $132.75K derived: sum of 2 quarters · filed 2022-11-09 | $153.95K 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | -$15.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $6.00K 10-Q · filed 2022-08-10 | |||||
| 2021-03-31 | $21.20K 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | $70.90K 10-K · filed 2022-03-22 | ||||||
| 2020-06-30 | $159.00K 10-Q · filed 2021-09-13 | ||||||
| 2019-12-31 | $399.90K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |